Antidiarrheal Efficacy and Cellular Mechanisms of a Thai Herbal Remedy

PLoS Neglected Tropical Diseases

Volumn 8, Issue 2, 2014, Pages

  Tradtrantip, Lukmanee ^a   Ko, Eun A ^a   Verkman, Alan S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ACTIVATED CHLORIDE CHANNEL; CALCIUM ION; CYCLIC AMP; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FORSKOLIN; HERBACEOUS AGENT; KRISANAKLAN EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIARRHEAL ACTIVITY; ARTICLE; CHOLERA; CONTROLLED STUDY; DIARRHEA; GASTROINTESTINAL MOTILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; INTESTINE CELL; INTESTINE CONTRACTION; MOUSE; NONHUMAN; ROTAVIRUS INFECTION; SECRETION (PROCESS); TRADITIONAL MEDICINE; WHOLE CELL PATCH CLAMP;

ANIMALS; ANTIDIARRHEALS; CHLORIDE CHANNELS; CHOLERA; DIARRHEA; DISEASE MODELS, ANIMAL; GASTROINTESTINAL MOTILITY; MICE; PLANT EXTRACTS; ROTAVIRUS INFECTIONS; THAILAND;

EID: 84895743756     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002674     Document Type: Article

References (48)

1. Walker CL, Rudan I, Liu L, Nair H, Theodoratou E, et al. (2013) Global burden of childhood pneumonia and diarrhoea. Lancet 381: 1405-1416.
2. Moore SR, Lima NL, Soares AM, Oriá RB, Pinkerton RC, et al. (2010) Prolonged episodes of acute diarrhea reduce growth and increase risk of persistent diarrhea in children. Gastroenterology 139: 1156-1164.
3. Guarino A, Dupont C, Gorelov AV, Gottrand F, Lee JK, et al. (2012) The management of acute diarrhea in children in developed and developing areas: from evidence base to clinical practice. Expert Opin Pharmacother 13: 17-26.
4. Harris JB, LaRocque RC, Qadri F, Ryan ET, Calderwood SB, (2012) Cholera. Lancet 379: 2466-76.
5. Munos MK, Walker CL, Black RE, (2010) The effect of oral rehydration solution and recommended home fluids on diarrhoea mortality. Int J Epidemiol 39: i75-87.
6. Venkatasubramanian J, Ao M, Rao MC, (2010) Ion transport in small intestine. Curr Opin Gastroentero 26: 123-128.
7. Murek M, Kopic S, Geibel J, (2010) Evidence for intestinal chloride secretion. Exp Physiol 95: 471-478.
8. Thiagarajah JR, Verkman AS, (2012) CFTR inhibitors for treating diarrhea disease. Clin Pharmacol Ther 92: 287-290.
9. Hoque KM, Woodward OM, van Rossum DB, Zachos NC, Chen L, et al. (2010) Epac1 mediates protein kinase A-independent mechanism of forskolin-activated intestinal chloride secretion. J Gen Physiol 135: 43-58.
10. Offit PA, Clark HF, Kornstein MJ, Plotkin SA, (1984) A murine model for oral infection with a primate rotavirus (simian SA11). J Viro 51: 233-236.
11. Morris AP, Scott JK, Ball JM, Zeng CQ, O'Neal WK, et al. (1999) NSP4 elicits age-dependent diarrhea and Ca(2+) mediated I(-) influx into intestinal crypts of CF mice. Am J Physiol 277: G431-444.
12. Greenberg HB, Estes MK, (2009) Rotaviruses: from pathogenesis to vaccination. Gastroenterology 136: 1939-1951.
13. Rufo PA, Lin PW, Andrade A, Jiang L, Rameh L, et al. (2004) Diarrhea-associated HIV-1 APIs potentiate muscarinic activation of Cl- secretion by T84 cells via prolongation of cytosolic Ca2+ signaling. Am J Physiol Cell Physiol 286: C998-C1008.
14. Hwang SJ, Blair PJ, Britton FC, O'Driscoll KE, Hennig G, et al. (2009) Expression of anoctamin 1/TMEM16A by interstitial cells of Cajal is fundamental for slow wave activity in gastrointestinal muscles. J Physiol 587: 4887-4904.
15. Huang F, Rock JR, Harfe BD, Cheng T, Huang X, et al. (2009) Studies on expression and function of the TMEM16A calcium-activated chloride channel. Proc Natl Acad Sci USA 106: 21413-21418.
16. Namkung W, Phuan PW, Verkman AS, (2011) TMEM16A inhibitors reveal TMEM16A as a minor component of calcium-activated chloride channel conductance in airway and intestinal epithelial cells. J Biol Chem 286: 2365-2374.
17. Verkman AS, Galietta LJ, (2009) Chloride channels as drug targets. Nat Rev Drug Discov 8: 153-171.
18. Thiagarajah J, Broadbent T, Hsieh E, Verkman AS, (2004) Prevention of toxin-induced intestinal ion and fluid secretion by a small-molecule CFTR inhibitor. Gastroenterology 126: 511-519.
19. Sonawane ND, Zhao D, Zegarra-Moran O, Galietta LJ, Verkman AS, (2007) Lectin conjugates as potent, nonabsorbable CFTR inhibitors for reducing intestinal fluid secretion in cholera. Gastroenterology 132: 1234-1244.
20. Yao Z, Namkung W, Ko EA, Park L, Tradtrantip L, Verkman AS, (2012) Fractionation of a herbal antidiarrheal medicine reveals eugenol as an inhibitor of Ca2+-activated Cl- channel TMEM16A. PLoS ONE 7: e38030.
21. Ma T, Thiagarajah JR, Yang H, Sonawane ND, Folli C, et al. (2002) Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. J Clin Invest 110: 1651-1658.
22. De La Fuente R, Namkung W, Mills A, Verkman AS, (2008) Small-molecule screen identifies inhibitors of a human intestinal calcium-activated chloride channel. Mol Pharmacol 73: 758-768.
23. Tradtrantip L, Namkung W, Verkman AS, (2010) Crofelemer, an antisecretory antidiarrheal proanthocyanidin oligomer extracted from Croton lechleri, targets two distinct intestinal chloride channels. Mol Pharmacol 77: 69-78.
24. Ko EA, Jin BJ, Namkung W, Ma T, Thiagarajah J, et al. (2013) Chloride channel inhibition by a red wine extract and a synthetic small molecule prevents rotaviral secretory diarrhea in neonatal mice. Sep 19doi:[]10.1136/gutjnl-2013-305663. [Epub ahead of print].
25. Namkung W, Yao Z, Finkbeiner WE, Verkman AS, (2011) Small-molecule activators of TMEM16A, a calcium-activated chloride channel, stimulate epithelial chloride secretion and intestinal contraction. FASEB J 25: 4048-4062.
26. Lundgren O, Peregrin AT, Persson K, Kordasti S, Uhnoo I, et al. (2000) Role of the enteric nervous system in the fluid and electrolyte secretion of rotavirus diarrhea. Science 287: 491-495.
27. Ousingsawat J, Mirza M, Tian Y, Roussa E, Schreiber R, et al. (2011) Rotavirus toxin NSP4 induces diarrhea by activation of TMEM16A and inhibition of Na+ absorption. Pflu{double acute}gers Arch 461: 579-589.
28. Seo NS, Zeng CQ, Hyser JM, Utama B, Crowford SE, et al. (2008) Integrins α1β1 and α2β2 are receptors for the rotavirus enterotoxin. Proc Natl Acad Sci USA 105: 8811-8818.
29. Coelho KI, Bryden AS, Hall C, Flewett TH, (1981) Pathology of rotavirus infection in suckling mice: A study by conventional histology, immunofluorescence, ultrathin sections, and scanning electron microscopy. Ultrastruct Pathol 2: 59-80.
30. Chao AC, de Sauvage FJ, Dong YJ, Wagner JA, Goeddel DV, Gardner P, (1994) Activation of intestinal CFTR Cl- channel by heat-stable enterotoxin and guanylin via cAMP-dependent protein kinase. EMBO J 13: 1065-1072.
31. Grubb BR, (1995) Ion transport across the jejunum in normal and cystic fibrosis mice. Am J Physiol 268: G505-513.
32. Berschneider HM, Knowles MR, Azizkhan RG, Boucher RC, Tobey NA, et al. (1988) Altered intestinal chloride transport in cystic fibrosis. FASEB J 2: 2625-2629.
33. O'Loughlin EV, Hunt DM, Gaskin KJ, Stiel D, Bruzuszcak IM, et al. (1991) Abnormal epithelial transport in cystic fibrosis jejunum. Am J Physiol 260: G758-763.
34. Namkung W, Finkbeiner WE, Verkman AS, (2010) CFTR-adenylyl cyclase I association responsible for UTP activation of CFTR in well-differentiated primary human bronchial cell cultures. Mol Biol Cell 21: 2639-2648.
35. Hempson SJ, Matkowskyi K, Bansal A, Tsao E, Habib I, et al. (2010) Rotavirus infection of murine small intestine causes colonic secretion via age restricted galanin-1 receptor expression. Gastroenterology 138: 2410-2417.
36. Kahn ME, Senderowicz A, Sausville EA, Barrett KE, (2001) Possible mechanisms of diarrheal side effects associated with the use of a novel chemotherapeutic agent, flavopiridol. Clin Cancer Res 7: 343-349.
37. MacArthur RD, Hawkins T, Brown SJ, LaMarca A, Chaturvedi P, et al. (2012) ADVENT Trial: Crofelemer for the treatment of secretory diarrhea in HIV+ individuals [poster 889] Conference on Retrovirueses and Opportunistic Infections (CROI) 2012- Seattle, WA. March 5-8, 2012.
38. de Hostos EL, Choy RK, Nguyen T, (2011) Developing novel antisecretory drugs to treat infectious diarrhea. Future Med Chem 3: 1317-1325.
39. Muanprasat C, Sonawane ND, Salinas D, Taddei A, Galietta LJ, et al. (2004) Discovery of glycine hydrazide pore-occluding CFTR inhibitors: mechanism, structure-activity analysis, and in vivo efficacy. J Gen Physiol 124: 125-137.
40. Jin BJ, Thiagarajah JR, Verkman AS, (2013) Convective washout reduces the antidiarrheal efficacy of enterocyte surface-targeted antisecretory drugs. J Gen Physiol 141: 261-272.
41. Sonawane ND, Zhao D, Zegarra-Moran O, Galietta LJ, Verkman AS, (2008) Nanomolar CFTR inhibition by pore-occluding divalent polyethylene glycol-malonic acid hydrazides. Chem Biol 15: 718-728.
42. Tradtrantip L, Sonawane ND, Namkung W, Verkman AS, (2009) Nanomolar potency pyrimido-pyrrolo-quinoxalinedione CFTR inhibitor reduces cyst size in a polycystic kidney disease model. J Med Chem 52: 6447-6455.
43. Snyder DS, Tradtrantip L, Yao C, Kurth MJ, Verkman AS, (2011) Potent, metabolically stable benzopyrimido-pyrrolo-oxazine-dione (BPO) CFTR inhibitors for polycystic kidney disease. J Med Chem 54: 5468-5477.
44. Namkung W, Thiagarajah JR, Phuan PW, Verkman AS, (2010) Inhibition of Ca2+-activated Cl- channels by gallotannins as a possible molecular basis for health benefits of red wine and green tea. FASEB J 24: 4178-4186.
45. Dash M, Patra JK, Panda PP, (2008) Phytochemical and antimicrobial screening of extracts of Aquilaria agallocha Roxb. Afr J Biotechnol 7: 3531-3534.
46. Sathyanathan V, Saraswathy A, Jayaraman P, (2012) Pharmacognostical studies on the wood of Aquilaria Malaccensis Lam. Int J Pharm & Ind Res 2: 416-423.
47. Shan B, Cai YZ, Sun M, Corke H, (2005) Antioxidant capacity of 26 spice extracts and characterization of their phenolic constituents. J Agric Food Chem 53: 7749-7759.
48. Nassar MI, Gaara AH, El-Ghorab AH, Farrag AH, Shen H, et al. (2007) Chemical constituents of clove (Syzygium aromaticum, Fam. Myrtaceae) and their antioxidant activity. Rev Latinoamer Quím 35: 47-57.